Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2014 Jan 8:12:4.
doi: 10.1186/1477-7819-12-4.

Poorly differentiated mesenteric carcinoma of unknown primary site detected by abscess formation: case report

Affiliations
Case Reports

Poorly differentiated mesenteric carcinoma of unknown primary site detected by abscess formation: case report

Yukinori Yamagata et al. World J Surg Oncol. .

Abstract

Background: Carcinoma of unknown primary site (CUP) is said to account for approximately 3 to 5% of all carcinomas. However, an isolated lesion in the abdominal cavity is rare, and there are no reports describing associated abscess formation.

Case presentation: A 76-year-old woman had consulted a previous physician complaining of fever and right lower quadrant abdominal pain. Enhanced computed tomography (CT) showed an abscess formation around the cecum. She was treated conservatively with antibiotics, but the symptoms relapsed and she consulted our hospital. Enhanced CT showed a persistent abscess, a tumorous lesion in the mesentery and right hydronephrosis. Because malignancy could not be ruled out, surgical treatment was selected. At laparotomy, encapsulated abscesses were found on the mesenteric side and outside of the ileocecal region. When we raised the ileocecal region, a tumor was found to be fixed to the right ureter, and there was leakage of white, solid tumor content. This tumor content was submitted to intraoperative frozen section diagnosis which revealed a carcinoma. Ileocecal resection with D3 lymph node dissection and retroperitoneal tumor resection was thus performed. There were no abnormal findings in the uterus and adnexa, nor any evidence of peritoneal dissemination. We regarded this case as an incomplete resection and chemotherapy with paclitaxel and carboplatin was administered. The patient has remained alive and disease-free for almost one year since the primary operation.

Conclusion: We described a case with mesenteric CUP discovered during surgery for an intra-abdominal abscess. It is necessary to pay attention to treatment-resistant intraperitoneal abscesses as they may accompany a tumor.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Re-examination by enhanced computed tomography (CT) scan. The CT scan shows right hydronephrosis (a), a tumorous lesion in the mesentery (b), and persistent encapsulated abscesses on the mesenteric side (c) and on the outside (d) of the ileocecal region.
Figure 2
Figure 2
Intraoperative findings. Encapsulated abscesses can be seen on the mesenteric side (a) and outside of the ileocecal region (b). When we raised the ileocecal region, a tumor was found to be fixed to the right ureter (c). A ureteral stent was inserted into the right ureter; the tumor was then separated and removed from the ureter (d).
Figure 3
Figure 3
Macroscopic findings of the tumor and ileocecal lesion. No changes involving the mucosal surface of the cecum or the terminal ileum were detected.
Figure 4
Figure 4
Histological and immunohistochemical findings of the tumor. Hematoxylin-eosin (HE) staining reveals poorly differentiated carcinoma (a). Alcian blue (AB) staining showed moderate production of mucin accompanied by a partial ductal structure (b). Immunohistochemistry was partially positive for CK34βE12 (about 20% of tumor) (c), positive for AE1/AE3 (d), negative for CDX2 (e), and negative for TTF-1 (f).

Similar articles

Cited by

References

    1. Pavlidis N, Briasoulis E, Hainsworth J, Greco FA. Diagnostic and therapeutic management of cancer of an unknown primary. Eur J Cancer. 2003;39:1990–2005. doi: 10.1016/S0959-8049(03)00547-1. - DOI - PubMed
    1. Matsubara N, Mukai H, Nagai S, Itoh K. Review of primary unknown cancer: cases referred to the national cancer center hospital east. Int J Clin Oncol. 2010;15:578–582. doi: 10.1007/s10147-010-0112-3. - DOI - PubMed
    1. Pentheroudakis G, Pavlidis N. Serous papillary peritoneal carcinoma: unknown primary tumour, ovarian cancer counterpart or a distinct entity? A systematic review. Crit Rev Oncol Hematol. 2010;75:27–42. doi: 10.1016/j.critrevonc.2009.10.003. - DOI - PubMed
    1. Hainsworth JD, Johnson DH, Greco FA. Cisplatin-based combination chemotherapy in the treatment of poorly differentiated carcinoma and poorly differentiated adenocarcinoma of unknown primary site: results of a 12-year experience. J Clin Oncol. 1992;10:912–922. - PubMed
    1. Park YH, Ryoo BY, Choi SJ, Yang SH, Kim HT. A phase II study of paclitaxel plus cisplatin chemotherapy in an unfavourable group of patients with cancer of unknown primary site. Jpn J Clin Oncol. 2004;34:681–685. doi: 10.1093/jjco/hyh124. - DOI - PubMed

Publication types